Pharmacokinetics of enteric-coated mycophenolate sodium in Chinese renal transplantation recipients

被引:11
|
作者
Qiu Kui [2 ]
Tian Hui [1 ]
Wang Wei [1 ]
Hu Xiao-peng [1 ]
Li Xiao-bei [1 ]
Gong Li-li [2 ]
Luo Wei [2 ]
Liu Li-hong [2 ]
Zhang Xiao-dong [1 ]
Yin Hang [1 ]
机构
[1] Capital Med Univ, Beijing Chao Yang Hosp, Dept Urol, Kidney Transplantat Program, Beijing 100020, Peoples R China
[2] Capital Med Univ, Beijing Chao Yang Hosp, Dept Pharmacol, Beijing 100020, Peoples R China
关键词
enteric-coated mycophenolate sodium; pharmacokinetics; limited sampling strategy; Chinese renal transplant recipients; LIMITED SAMPLING STRATEGIES; GASTROINTESTINAL INTOLERANCE; ACID EXPOSURE; MPA EXPOSURE; MOFETIL; KIDNEY; BIOEQUIVALENCE; PERFORMANCE; VALIDATION; EFFICACY;
D O I
10.3760/cma.j.issn.0366-6999.2012.23.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Mycophenolic acid (MPA) as an anti-proliferative immune-suppressive agent is used in the majority of immunosuppressive regimens in solid organ transplantation. This study aimed to investigate the pharmacokinetic (PK) characteristics of enteric-coated mycophenolate sodium (EC-MPS) and area under the curve (AUC) from 0 to 12 hours with limited sampling strategies (LSSs) in Chinese renal transplant recipients. Methods This study was conducted in 10 Chinese renal transplant patients receiving living donor and treated with EC-MPS, cyclosporine, and corticosteroids. MPA concentrations were measured by enzyme multiplied immunoassay technique (EMIT). Whole 12-hour PK profiles were obtained on Day 4 after operation. LSSs with jackknife technique, multiple stepwise regression analysis, and Bland-Altman analysis were developed to estimate MPA AUC. Results The mean maximum plasma concentration, the mean time for it to reach peak (T-max), and the mean MPA AUC were (11.38 +/- 2.49) mg/L, (4.85 +/- 3.32) hours, and (63.19 +/- 13.54) mg.h.L-1, respectively. Among the 10 profiles, MPA AUC of four patients was significantly higher than that of the other six patients, and the corresponding T-max was significantly longer than that of the other six patients. No patient exhibited a second peak caused by enterohepatic recirculation. The best models were as follows: 27.46+0.94C(3)+3.24C(8)+2.81C(10) (r(2)=0.972), which was used to predict AUC of fast metabolizer with a mean prediction error (MPE) of -0.21% and a mean absolute prediction error (MAE) of 2.59%; 36.65+3.08C(8)+5.30C(10)-4.04C(12) (r(2)=0.992), which was used to predict AUC of slow metabolizer with a MPE of 0.58% and a MAE of 1.95%. Conclusions The PKs of EC-MPS had a high variability among Chinese renal transplant recipients. The preliminary PK data indicated the existence of slow and fast metabolizer. These findings may be associated with the enterohepatic recirculation. Chin Med J 2012;125(23):4226-4232
引用
收藏
页码:4226 / 4232
页数:7
相关论文
共 50 条
  • [1] Pharmacokinetics of enteric-coated mycophenolate sodium in Chinese renal transplantation recipients
    QIU Kui
    TIAN Hui
    WANG Wei
    HU Xiao-peng
    LI Xiao-bei
    GONG Li-li
    LUO Wei
    LIU Li-hong
    ZHANG Xiao-dong
    YIN Hang
    [J]. 中华医学杂志(英文版), 2012, (23) : 4226 - 4232
  • [2] Pharmacokinetics of enteric-coated mycophenolate sodium and determination of AUC by LSS in Chinese renal transplantation recipients
    Qiu, K.
    Yin, H.
    Wang, H.
    Zhang, X. D.
    [J]. THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 538 - 539
  • [3] Pharmacokinetics of enteric-coated mycophenolate sodium in stable pediatric renal transplant recipients
    Ettenger, R
    Bartosh, S
    Choi, L
    Zhu, W
    Niederberger, W
    Campestrini, J
    Bastien, MC
    Schmouder, R
    [J]. PEDIATRIC TRANSPLANTATION, 2005, 9 (06) : 780 - 787
  • [4] Pharmacokinetics of Mycophenolic Acid Following Enteric-Coated Mycophenolate Sodium Administration in Chinese Renal Transplant Recipients.
    Peng, W.
    Tian, C.
    Chen, Z.
    Xue, W.
    Wang, G.
    Ye, Q.
    Zhang, X.
    Gu, M.
    Zhao, M.
    Wang, C.
    Huang, C.
    Yan, J.
    Zhang, W.
    Ding, C.
    Fu, Y.
    Ye, S.
    Hu, X.
    Tan, R.
    Li, M.
    Deng, R.
    Ke, Y.
    Wu, W.
    Fan, M.
    Chen, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 806 - 807
  • [5] Pharmacokinetics of enteric-coated mycophenolate sodium in stable liver transplant recipients
    Perry, Theodore W.
    Christians, Uwe
    Trotter, James F.
    Bendrick-Peart, Jamie
    [J]. CLINICAL TRANSPLANTATION, 2007, 21 (03) : 413 - 416
  • [6] Population Pharmacokinetics of Mycophenolic Acid A Comparison between Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil in Renal Transplant Recipients
    de Winter, Brenda C. M.
    van Gelder, Teun
    Glander, Petra
    Cattaneo, Dario
    Tedesco-Silva, Helio
    Neumann, Irmgard
    Hilbrands, Luuk
    van Hest, Reinier M.
    Pescovitz, Mark D.
    Budde, Klemens
    Mathot, Ron A. A.
    [J]. CLINICAL PHARMACOKINETICS, 2008, 47 (12) : 827 - 838
  • [7] Population Pharmacokinetics of Mycophenolic AcidA Comparison between Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil in Renal Transplant Recipients
    Brenda C. M. de Winter
    Teun van Gelder
    Petra Glander
    Dario Cattaneo
    Helio Tedesco-Silva
    Irmgard Neumann
    Luuk Hilbrands
    Reinier M. van Hest
    Mark D. Pescovitz
    Klemens Budde
    Ron A. A. Mathot
    [J]. Clinical Pharmacokinetics, 2008, 47 : 827 - 838
  • [8] Comparison of enteric-coated mycophenolate sodium with mycophenolate mofetil in living renal allograft transplantation
    Minz, M.
    Sharma, A.
    Heer, M.
    [J]. TRANSPLANTATION PROCEEDINGS, 2006, 38 (07) : 2041 - 2043
  • [9] Gastrointestinal Quality of Life Improvement of Renal Transplant Recipients Converted From Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Drugs or Agents: Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium
    Ortega, Francisco
    Sanchez-Fructuoso, Ana
    Maria Cruzado, Jose
    Carlos Gomez-Alamillo, Juan
    Alarcon, Antonio
    Pallardo, Lluis
    Maria Morales, Jose
    Oliver, Juan
    Guinea, Guillermo
    [J]. TRANSPLANTATION, 2011, 92 (04) : 426 - 432
  • [10] Enteric-coated mycophenolate sodium
    Budde, Klemens
    Duerr, Michael
    Liefeldt, Lutz
    Neumayer, Hans-Hellmut
    Glander, Petra
    [J]. EXPERT OPINION ON DRUG SAFETY, 2010, 9 (06) : 981 - 994